The Trump administration is adding over 600 generic drugs to its TrumpRx website, aiming to lower prescription costs. The platform now features tools to find the cheapest local pharmacies and offers home delivery, partnering with companies like Mark Cuban's Cost Plus Drug Company and Amazon Pharmacy.
China's volume-based procurement policy, which mandates bulk drug purchases for public hospitals, is intensifying price competition for multinational pharmaceutical companies while creating more profitable channels for domestic biotech firms in the private market. Analysts note potential benefits for internet healthcare platforms, pharmacies, and private hospital services.
China's volume-based procurement policy forces multinational drug companies to lower prices for public hospital purchases while allowing biotech firms to charge premium prices in the private market. The dual-track system benefits internet healthcare platforms and private healthcare providers like Alibaba Health, Yifeng and Hygeia, according to Citi research.
